Neonatal Fc Receptor Blockers has 3 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Eculizumab, Eculizumab-Aagh, Eculizumab-Aeeb. Patients taking Neonatal Fc Receptor Blockers should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 3
- Moderate
- 3
Moderate (3)
- Neonatal Fc Receptor Blockers + Eculizumab— Concomitant use may lower systemic exposures and reduce effectiveness of SOLIRIS. Closely monitor for reduced effectiven…
- Neonatal Fc Receptor Blockers + Eculizumab-Aagh— Concomitant use may lower systemic exposures and reduce effectiveness of eculizumab. Closely monitor for reduced effecti…
- Neonatal Fc Receptor Blockers + Eculizumab-Aeeb— Concomitant use may lower systemic eculizumab exposures and reduce effectiveness; close monitoring required.